Kosuke Watari
Higashi, 8128582, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
A multi-functional oral small molecule targeting energy and lipid metabolism to treat obesity and related metabolic disorders.
Journal: Science advances
Published: August 21, 2026
Hepatocyte-intrinsic ER stress and NRF2 initiate primary sclerosing cholangitis, providing therapeutic insights.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 11, 2026
Author Correction: Mitochondrial DNA oxidation propagates autoimmunity by enabling plasmacytoid dendritic cells to induce TFH differentiation.
Journal: Nature immunology
Published: July 31, 2026
Inflammatory memory disables a DDR1 degradation checkpoint to enable pancreatic cancer growth.
Journal: bioRxiv : the preprint server for biology
Published: April 10, 2026
Selective targeting of NRF2-high pancreatic ductal adenocarcinoma with an NQO1-activatable prodrug.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 21, 2026
Author Correction: FBP1 controls liver cancer evolution from senescent MASH hepatocytes.
Journal: Nature
Published: January 31, 2025
Innate immune cells link dietary cues to normal and abnormal metabolic regulation.
Journal: Nature immunology
Published: January 12, 2024
IL-22 resolves MASLD via enterocyte STAT3 restoration of diet-perturbed intestinal homeostasis.
Journal: Cell metabolism
Published: September 30, 2023
FBP1 controls liver cancer evolution from senescent MASH hepatocytes.
Journal: Nature
Published: July 22, 2023
Fructose-1,6-bisphosphatase is a nonenzymatic safety valve that curtails AKT activation to prevent insulin hyperresponsiveness.
Journal: Cell metabolism
Published: November 29, 2022
Last Updated: 09/26/2026